NPs Basic Information
|
Name |
xylariahgin A
|
| Molecular Formula | C11H12O4 | |
| IUPAC Name* |
4-(4-ethyl-5-oxooxolan-2-yl)pyran-2-one
|
|
| SMILES |
CCC1CC(c2ccoc(=O)c2)OC1=O
|
|
| InChI |
InChI=1S/C11H12O4/c1-2-7-5-9(15-11(7)13)8-3-4-14-10(12)6-8/h3-4,6-7,9H,2,5H2,1H3/t7-,9-/m1/s1
|
|
| InChIKey |
KTJVQZRMTKSKHC-VXNVDRBHSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was calculated by STOUT. Reference: PMID:33906675.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 208.21 | ALogp: | 1.7 |
| HBD: | 0 | HBA: | 4 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 56.5 | Aromatic Rings: | 2 |
| Heavy Atoms: | 15 | QED Weighted: | 0.699 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -4.562 | MDCK Permeability: | 0.00003040 |
| Pgp-inhibitor: | 0.045 | Pgp-substrate: | 0.003 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.009 |
| 30% Bioavailability (F30%): | 0.915 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.861 | Plasma Protein Binding (PPB): | 72.96% |
| Volume Distribution (VD): | 0.75 | Fu: | 47.57% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.333 | CYP1A2-substrate: | 0.485 |
| CYP2C19-inhibitor: | 0.456 | CYP2C19-substrate: | 0.166 |
| CYP2C9-inhibitor: | 0.203 | CYP2C9-substrate: | 0.294 |
| CYP2D6-inhibitor: | 0.03 | CYP2D6-substrate: | 0.317 |
| CYP3A4-inhibitor: | 0.09 | CYP3A4-substrate: | 0.38 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 9.763 | Half-life (T1/2): | 0.56 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.087 | Human Hepatotoxicity (H-HT): | 0.125 |
| Drug-inuced Liver Injury (DILI): | 0.19 | AMES Toxicity: | 0.015 |
| Rat Oral Acute Toxicity: | 0.194 | Maximum Recommended Daily Dose: | 0.659 |
| Skin Sensitization: | 0.124 | Carcinogencity: | 0.465 |
| Eye Corrosion: | 0.069 | Eye Irritation: | 0.574 |
| Respiratory Toxicity: | 0.82 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005453 |  |
0.474 | D08SKH |  |
0.239 | ||
| ENC004862 |  |
0.317 | D05EPM |  |
0.235 | ||
| ENC005451 |  |
0.308 | D06BYV |  |
0.227 | ||
| ENC005452 |  |
0.294 | D06HLY |  |
0.217 | ||
| ENC006021 |  |
0.268 | D0K7LU |  |
0.213 | ||
| ENC004027 |  |
0.264 | D07MGA |  |
0.212 | ||
| ENC000292 |  |
0.245 | D0Z8EX |  |
0.211 | ||
| ENC002869 |  |
0.244 | D0Z9NZ |  |
0.208 | ||
| ENC004861 |  |
0.242 | D0U5RT |  |
0.208 | ||
| ENC004766 |  |
0.242 | D0S5CH |  |
0.208 | ||